Published in J Immunol on November 01, 1971
Predominant contribution of IgA antibody-forming cells to an immune response detected in extraintestinal lymphoid tissues of germ-free mice exposed to antigen by the oral route. J Immunol (1970) 2.06
Mechanisms influencing the immunodominance of T cell determinants. J Exp Med (1988) 1.91
Interaction of an immunodominant epitope with Ia molecules in T-cell activation. Proc Natl Acad Sci U S A (1988) 1.51
Growth rate of primary breast cancer and prognosis: observations on a 3- to 7-year follow-up in 180 breast cancers. Br J Cancer (1986) 1.42
Enhancing activity of thymocyte culture cell-free medium on the in vitro immune response of spleen cells from neonatally thymectomized mice to sheep RBC. J Immunol (1972) 1.34
Competition for antigen presentation in living cells involves exchange of peptides bound by class II MHC molecules. Nature (1989) 1.26
Age-dependent variations of antibody avidity. Immunology (1978) 1.13
In vitro primary immune response resulting from the interaction between bone marrow-derived and thymus cells. Experientia (1970) 1.10
Use of hematopoietic cytokines to accelerate the recovery of the immune system in irradiated mice. Exp Hematol (1997) 1.10
IL-11 synergizes with IL-3 in promoting the recovery of the immune system after irradiation. Int Immunol (1996) 1.10
Structural requirements for the interaction between peptide antigens and I-Ed molecules. J Immunol (1989) 1.09
Usefulness of breast self-examination for an early detection of breast cancer results of a study on 500 breast cancer patients and 652 controls. Tumori (1981) 1.08
Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation. Int J Immunopharmacol (1993) 1.06
Androgens and breast cancer in premenopausal women. Cancer Res (1989) 1.03
Inheritance of immune responsiveness, life span, and disease incidence in interline crosses of mice selected for high or low multispecific antibody production. J Immunol (1989) 1.03
The effect of thymic action on the precursors of antigen-sensitive cells. Proc Natl Acad Sci U S A (1967) 1.02
Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res (1991) 1.02
A microcomputer program for probit analysis of interleukin-2 (IL-2) titration data. J Immunol Methods (1986) 1.00
Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab (1969) 1.00
Levels of some trace elements in selected autopsy organs, and in hair and blood samples from adult subjects of the Italian population. Biol Trace Elem Res (1991) 0.99
[Clinical trials with adriamycin in leukemia and solid tumors]. Tumori (1969) 0.98
In vivo restoration of T cell functions by human IL-1 beta or its 163-171 nonapeptide in immunodepressed mice. J Immunol (1988) 0.98
Heterogeneity of mouse myeloma gamma G globulins as revealed by enzymatic proteolysis. J Immunol (1969) 0.98
Selective effects of ionizing radiations on immunoregulatory cells. Immunol Rev (1982) 0.97
Prognostic significance of the growth rate of breast cancer: preliminary evaluation on the follow-up of 196 breast cancers. Tumori (1981) 0.96
Pneumothorax: a rare complication of fine needle aspiration of the breast. Acta Cytol (1989) 0.96
Thymus dependence of adoptive immunity in irradiated mice. Transplantation (1968) 0.94
Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production. J Immunol (1985) 0.93
In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta. J Exp Med (1988) 0.93
The rise and fall of antibody avidity at the level of single immunocytes. J Immunol (1972) 0.93
Enhancement of the immune response in mice by Astragalus membranaceus extracts. Immunopharmacology (1991) 0.91
Gangliosides and neurological diseases. BMJ (1993) 0.90
Rearrangement and expression of the alpha- and beta-chain genes of the T-cell antigen receptor in functional murine suppressor T-cell clones. Proc Natl Acad Sci U S A (1985) 0.88
Defective antigen presentation by macrophages from mice genetically selected for low antibody response. Eur J Immunol (1981) 0.88
The metabolism of different immunoglobulin classes in irradiated mice. 3. Effects of supra-lethal doses of x-rays. Int J Radiat Biol Relat Stud Phys Chem Med (1970) 0.88
Effect of carrier priming on antibody avidity in the in vivo and in vitro immune response. Immunology (1977) 0.88
Synergism between two helper cell subpopulations characterized by different radiosensitivity and nylon adherence. J Immunol (1981) 0.88
Inhibition of IgG1 and IgE production by stimulation of the B cell CTLA-4 receptor. J Immunol (2000) 0.88
Accuracy of breast cancer diagnosis by physical, radiologic and cytologic combined examinations. Tumori (1983) 0.88
Synthesis and antiulcer activity of (E)-5-[2-(3-pyridyl)ethenyl]-1H,7H-pyrazolo [1,5-a]pyrimidine-7-ones. Farmaco Sci (1986) 0.88
High testosterone and low progesterone circulating levels in premenopausal patients with hyperplasia and cancer of the breast. Cancer Res (1984) 0.87
Diagnostic efficacy of the clinical-radiological-cytological triad in solid breast lumps: results of a second prospective study on 631 patients. Eur J Surg Oncol (1987) 0.87
Melatonin restores immunodepression in aged and cyclophosphamide-treated mice. Ann N Y Acad Sci (1994) 0.87
Cardinal directions for visual optic flow. Curr Biol (1999) 0.86
Differential effects of gonadectomy on thymic stromal cells in promoting T cell differentiation in mice. Mech Ageing Dev (1995) 0.86
Production of antigen-specific suppressive T cell factor by radiation leukemia virus-transformed suppressor T cells. Proc Natl Acad Sci U S A (1981) 0.86
Recovery of the hemolysin response in mouse radiation chimeras. Transplantation (1968) 0.86
Biological effects of Escherichia coli lipopolysaccharide (LPS) in vivo. II. Selection in the mouse thymus of PHA- and con A-responsive cells. Immunology (1976) 0.86
Immunoregulation of lysozyme-specific suppression. II. Hen egg-white lysozyme-specific monoclonal suppressor T cell factor suppresses the afferent phase of delayed-type hypersensitivity and induces second-order suppressor T cells. Eur J Immunol (1984) 0.86
Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and blood cells. Bone Marrow Transplant (2000) 0.86
Fine antigenic specificity and genetic restriction of lysozyme-specific suppressor T cell factor produced by radiation leukemia virus-transformed suppressor T cells. Eur J Immunol (1982) 0.85
Phosphatidylserine-induced modulation of the immune response in mice: effect of intravenous administration. Immunopharmacology (1990) 0.85
Neuropeptide Y plasma levels and immunological changes during academic stress. Neuropsychobiology (1999) 0.85
Role of mRNA stability in the different patterns of cytokine production by CD4+ cells from young and old mice. Immunology (1998) 0.84
Genetics of chemical carcinogenesis. 1. Bidirectional selective breeding of susceptible and resistant lines of mice to two-stage skin carcinogenesis. Carcinogenesis (1990) 0.84
Cell proliferation and ku protein expression in ageing humans. Mech Ageing Dev (1998) 0.83
Clinical nutrition in gerontology: chronic renal disorders of the dog and cat. Vet Res Commun (2005) 0.83
Cross-reactivity between human thymus and mouse lymphoid tissues, as revealed by rabbit antiserum against human brain. Proc Soc Exp Biol Med (1975) 0.83
Enhanced frequency of mitogen-responsive T cell precursors in old mice injected with thymosin alpha 1. Eur J Immunol (1987) 0.82
Clinical findings associated with Borrelia burgdorferi infection in the dog. Vet Res Commun (2003) 0.82
Enhanced antibody affinity in sublethally irradiated mice and bone marrow chimeras. Proc Natl Acad Sci U S A (1977) 0.82
Effect of age on DNA binding of the ku protein in irradiated human peripheral blood mononuclear cells (PBMC). Exp Gerontol (1999) 0.82
Establishment of functional, antigen-specific T cell lines by radLV-induced transformation of murine T lymphocytes. Curr Top Microbiol Immunol (1982) 0.82
Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology (1992) 0.82
Hormone replacement therapy affects various immune cell subsets and natural cytotoxicity. Gynecol Obstet Invest (1996) 0.81
Analysis of lysozyme-specific immune responses by synthetic peptides. I. Characterization of antibody and T cell-mediated responses to the N-terminal peptide of hen egg-white lysozyme. Eur J Immunol (1986) 0.81
Immunoregulation in senescence: increased inducibility of antigen-specific suppressor T cells and loss of cell sensitivity to immunosuppression in aging mice. Proc Natl Acad Sci U S A (1982) 0.81
Recovery of T-cell functions in aged mice injected with synthetic thymosin-alpha 1. Cell Immunol (1982) 0.81
Oscillations of IgM antibody affinity at the level of single immunocytes. J Immunol (1980) 0.81
Induction of azobenzenearsonate- (ABA) specific helper and suppressor T cells and in vitro evaluation of their activities in the antibody response to T-dependent ABA-protein conjugates. J Immunol (1981) 0.81
In vivo immunopotentiating activity of thymopentin in aging humans: increase of IL-2 production. Clin Immunol Immunopathol (1987) 0.81
Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Diabet Med (2010) 0.81
Problems in fine-needle aspiration biopsy cytology of clinically or mammographically uncertain breast tumors. Tumori (1982) 0.81
Leukocyte modifications during the first month after foaling in mares and their newborn foals. Pol J Vet Sci (2015) 0.80
T cell receptor-homologous mRNA from a suppressor T cell clone directs the synthesis of antigen-specific suppressive products. Eur J Immunol (1987) 0.80
Genetics of chemical carcinogenesis: analysis of bidirectional selective breeding inducing maximal resistance or maximal susceptibility to 2-stage skin tumorigenesis in the mouse. Int J Cancer (2000) 0.80
Androgen excretion in women with a family history of breast cancer or with epithelial hyperplasia or cancer of the breast. Eur J Cancer Clin Oncol (1983) 0.80
Systematic use of the clinical-mammographic-cytologic triplet for the early diagnosis of mammary carcinoma. Tumori (1985) 0.80
Time and antigen dose-dependent variations of IgM antibody affinity. Eur J Immunol (1978) 0.80
Secretion rate independent evaluation of IgM antibody avidity at the level of single immunocytes. J Immunol (1978) 0.80
Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation. Eur J Immunol (1999) 0.80
Changes in thymocyte subsets induced by estradiol administration or pregnancy. Ann N Y Acad Sci (1992) 0.80
Localized mastalgia as presenting symptom in breast cancer. Eur J Surg Oncol (1988) 0.80
Diffusion-weighted imaging in patients with progressive multifocal leukoencephalopathy. Eur Radiol (2008) 0.79
Reconstitution of T cell functions in aging mice by thymosin alpha 1. Immunopharmacology (1986) 0.79
Immunologically competent thymus cells of bone marrow origin. Nature (1969) 0.79
Linkage disequilibrium and haplotype mapping of a skin cancer susceptibility locus in outbred mice. Mamm Genome (2000) 0.79
Heterogeneity of immune responsiveness in healthy elderly subjects. Clin Immunol Immunopathol (1988) 0.79
Immunosuppression by cell-free translation products from monoclonal antigen-specific suppressor T cell mRNA. Eur J Immunol (1985) 0.79
Two distinct azobenzenearsonate-specific helper T-cell subpopulations mediate different forms of T-B cooperation. Scand J Immunol (1983) 0.79